X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (298) 298
Publication (55) 55
Book Chapter (19) 19
Conference Proceeding (12) 12
Dissertation (3) 3
Book Review (1) 1
Patent (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (52) 52
index medicus (44) 44
female (36) 36
oncology (35) 35
trihalomethanes (32) 32
environmental sciences (31) 31
male (31) 31
greece (23) 23
middle aged (23) 23
adult (20) 20
aged (20) 20
chemotherapy (20) 20
physics, fluids & plasmas (20) 20
chlorination (19) 19
cancer (18) 18
drinking water (18) 18
abstracts (17) 17
disinfection by-products (17) 17
drinking-water (16) 16
water resources (16) 16
water pollutants, chemical - analysis (15) 15
haloacetic acids (14) 14
article (13) 13
human (13) 13
analysis (12) 12
engineering, environmental (12) 12
70 plasma physics and fusion technology (11) 11
prognosis (11) 11
tokamak (11) 11
water supply (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
athens (10) 10
engineering, chemical (10) 10
neoplasms (10) 10
plasma (10) 10
survival (10) 10
aged, 80 and over (9) 9
alcator c-mod (9) 9
clinical trials (9) 9
kefir (9) 9
research (9) 9
transport (9) 9
trihalomethanes - analysis (9) 9
turbulence (9) 9
colorectal cancer (8) 8
confinement (8) 8
dihaloacetonitriles (8) 8
glioblastoma (8) 8
review (8) 8
tokamak devices (8) 8
tumors (8) 8
adolescent (7) 7
bevacizumab (7) 7
brain neoplasms - drug therapy (7) 7
cancer of unknown primary (7) 7
cancer research (7) 7
chlorination by-products (7) 7
environmental monitoring (7) 7
fermentation (7) 7
fluctuations (7) 7
haloketones (7) 7
hematology, oncology and palliative medicine (7) 7
kinetics (7) 7
lactose (7) 7
lactose uptake (7) 7
patients (7) 7
physics (7) 7
priority journal (7) 7
radiotherapy (7) 7
temperature (7) 7
water treatment plants (7) 7
alcator device (6) 6
biomarkers (6) 6
breast cancer (6) 6
clinical trial (6) 6
dbps (6) 6
disease-free survival (6) 6
fulvic-acid (6) 6
gene expression (6) 6
glioblastoma - drug therapy (6) 6
humic substances (6) 6
immunohistochemistry (6) 6
irinotecan (6) 6
kaplan-meier estimate (6) 6
medicine & public health (6) 6
plasmas (6) 6
prospective studies (6) 6
quality of life (6) 6
temozolomide (6) 6
tomography, x-ray computed (6) 6
unknown primary (6) 6
whey fermentation (6) 6
antineoplastic combined chemotherapy protocols (5) 5
brain neoplasms - mortality (5) 5
brain, infants and children (5) 5
cancer of unknown primary site (5) 5
cancer survival (5) 5
cancer therapies (5) 5
chemistry, analytical (5) 5
chemotherapy, adjuvant (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 2007, Volume 43, Issue 14, pp. 2026 - 2036
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 11, pp. 1027 - 1037
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 20, pp. 1954 - 1963
The addition of bevacizumab to lomustine in patients with recurrent glioblastoma failed to increase overall survival but was associated with a small increase... 
Medicine(all) | MEDICINE, GENERAL & INTERNAL | METHYLATION | PROGNOSTIC-FACTORS | PLUS IRINOTECAN | SINGLE-AGENT BEVACIZUMAB | RESPONSE ASSESSMENT | CLINICAL-TRIALS | PHASE-2 | QUALITY-OF-LIFE | RADIOTHERAPY | TEMOZOLOMIDE | Bevacizumab - administration & dosage | Bevacizumab - adverse effects | Humans | Lomustine - adverse effects | Middle Aged | Kaplan-Meier Estimate | Male | Antineoplastic Agents, Alkylating - administration & dosage | Brain Neoplasms - drug therapy | Chemoradiotherapy | Glioblastoma - radiotherapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Aged, 80 and over | Adult | Female | Aged | Brain Neoplasms - mortality | Antineoplastic Agents, Alkylating - adverse effects | Brain Neoplasms - radiotherapy | Glioblastoma - drug therapy | Glioblastoma - mortality | Lomustine - administration & dosage | Patient outcomes | Lomustine | Outcome and process assessment (Health Care) | Dosage and administration | Research | Drug therapy | Glioblastoma multiforme | Methods | Medical research | Nuclear magnetic resonance--NMR | Brain cancer | Methylguanine | Glioblastoma | Clinical trials | Oncology | Cognition | Cancer therapies | Survival | Quality of life | Bevacizumab | O6-methylguanine-DNA methyltransferase | Studies | Brain research | DNA methylation | DNA methyltransferase | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1533 - 1542
Journal Article
Journal Article
Analytical Letters, ISSN 0003-2719, 05/2016, Volume 49, Issue 7, pp. 887 - 895
The organic substances most frequently reported as precursors of trihalomethanes in public water are naturally occurring humates found in surface water and... 
on-column injection | chloroform | Algae | chlorination | gas chromatography | oxygen | water | TRIHALOMETHANES | GREECE | CHEMISTRY, ANALYTICAL | DISINFECTION BY-PRODUCTS | ATHENS | WATER-SUPPLY SYSTEM | DRINKING-WATER | VOLATILE ORGANIC-COMPOUNDS | Gas chromatography | Drinking water | Injectors | Chlorination | Chloroform | Precursors | Chlorine
Journal Article
NeuroImage, ISSN 1053-8119, 04/2011, Volume 55, Issue 3, pp. 1324 - 1338
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 05/2018, Volume 33, Issue suppl_1, pp. i5 - i5
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2012, Volume 84, Issue 1, pp. 85 - 92
Journal Article